ArticleDermatology and therapy2024

Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.